X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SHASUN PHARMA DR. DATSONS LABS/
SHASUN PHARMA
 
P/E (TTM) x -10.9 123.9 - View Chart
P/BV x 0.2 8.5 1.9% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   SHASUN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SHASUN PHARMA
Mar-14
DR. DATSONS LABS/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs12694 133.3%   
Low Rs3146 67.8%   
Sales per share (Unadj.) Rs133.0214.2 62.1%  
Earnings per share (Unadj.) Rs0.25.3 2.8%  
Cash flow per share (Unadj.) Rs6.615.8 41.8%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs128.853.3 241.4%  
Shares outstanding (eoy) m31.6656.62 55.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 180.3%   
Avg P/E ratio x516.113.1 3,939.9%  
P/CF ratio (eoy) x11.84.4 268.0%  
Price / Book Value ratio x0.61.3 46.4%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m2,4773,958 62.6%   
No. of employees `000NANA-   
Total wages/salary Rs m562,164 2.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21112,127 34.7%  
Other income Rs m79229 34.3%   
Total revenues Rs m4,28912,356 34.7%   
Gross profit Rs m5691,009 56.4%  
Depreciation Rs m204594 34.4%   
Interest Rs m430415 103.6%   
Profit before tax Rs m13230 5.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20 600.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-73 -8.4%   
Profit after tax Rs m5302 1.6%  
Gross profit margin %13.58.3 162.3%  
Effective tax rate %48.0-31.7 -151.7%   
Net profit margin %0.12.5 4.6%  
BALANCE SHEET DATA
Current assets Rs m6,8526,884 99.5%   
Current liabilities Rs m6,7118,456 79.4%   
Net working cap to sales %3.3-13.0 -25.8%  
Current ratio x1.00.8 125.4%  
Inventory Days Days16162 261.0%  
Debtors Days Days318108 296.1%  
Net fixed assets Rs m3,6734,970 73.9%   
Share capital Rs m317113 279.4%   
"Free" reserves Rs m3,7612,875 130.8%   
Net worth Rs m4,0783,020 135.0%   
Long term debt Rs m1,6711,817 91.9%   
Total assets Rs m12,63313,347 94.6%  
Interest coverage x1.01.6 66.3%   
Debt to equity ratio x0.40.6 68.1%  
Sales to assets ratio x0.30.9 36.7%   
Return on assets %3.45.4 64.1%  
Return on equity %0.110.0 1.2%  
Return on capital %7.713.3 57.6%  
Exports to sales %22.946.4 49.4%   
Imports to sales %14.314.2 100.3%   
Exports (fob) Rs m9645,622 17.1%   
Imports (cif) Rs m6021,728 34.8%   
Fx inflow Rs m9645,843 16.5%   
Fx outflow Rs m6072,173 27.9%   
Net fx Rs m3573,669 9.7%   
CASH FLOW
From Operations Rs m1,345398 338.2%  
From Investments Rs m-2,256-1,635 138.0%  
From Financial Activity Rs m-1,2001,309 -91.7%  
Net Cashflow Rs m-2,11171 -2,964.5%  

Share Holding

Indian Promoters % 4.5 39.2 11.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.6 -  
FIIs % 1.4 17.6 7.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 39.6 237.6%  
Shareholders   20,807 20,750 100.3%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  ASTRAZENECA PHARMA  BIOCON LTD  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - CADILA HEALTHCARE COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS